| Issue Date | Title | Author(s) |
1 | 2022 | Adding pneumatic compression therapy in lower extremity lymphedema increases compliance of treatment, while decreasing the infection rate | Soran, Atilla; Toktaş, Osman; Grassi, Ariel; Sezgin, Efe |
2 | Oct-2022 | ASO visual abstract: Intervention for hepatic and pulmonary METastases in breast cancer patients-prospective, multi-institutional registry study: IMET; Protocol MF 14-02 | Soran, Atilla; Özbaş, Serdar; Özçınar, Beyza; Işık, Arda; Doğan, L.; Şenol, Kazım; Dağ, Ahmet; Karanlık, Hasan; Aytaç, Özgür; Karadeniz Çakmak, Güldeniz; Dalcı, Kubilay; Doğan, Mutlu; Sezer, Atakan Y.; Gökgöz, Şehsuvar; Özyar, Enis; Sezgin, Efe |
3 | 2019 | Can post-mastectomy radiation therapy be omitted in T1-2 clinically node-negative breast cancer patients with a positive sentinel lymph node biopsy? | Dinh, Kate; Soran, Atilla; Işık, Arda; McAuliffe, Priscilla; Diego, Emilia; Sezgin, Efe ; Johnson, Ronald |
4 | 2023 | Correction: Intervention for hepatic and pulmonary metastases in breast cancer patients: Prospective, multi-institutional registry Study–IMET, Protocol MF 14-02 | Soran, Atilla; Özbaş, Serdar; Özçınar, Beyza; Işık, Arda; Doğan, Lütfi; Şenol, Kazım; Sezgin, Efe |
5 | 2021 | Correspondence to “Locoregional therapy in de novo metastatic breast cancer: Systematic review and meta-analysis, written by Reinhorn D et al. In The Breast Journal 58 (2021) 173–181” | Soran, Atilla; Özbaş, Serdar; Doğan, Lütfi; Işık, Arda; Sezgin, Efe |
6 | 2019 | Does locoregional treatment in de novo stage IV bone-only metastatic breast cancer prolong survival? An ongoing multicenter registry study | Soran, Atilla; Işık, Arda; Doğan, Lütfi; Sezgin, Efe ; Özbaş, Serdar |
7 | 2021 | The effect of primary surgery in patients with de novo stage IV breast cancer with bone metastasis only (Protocol BOMET MF 14-01): A multi-center, prospective registry study | Soran, Atilla; Doğan, Lütfi; Işık, Arda; Özbaş, Serdar; Trabulus, Didem Can; Demirci, Umut; Sezgin, Efe |
8 | 2021 | The effect of primary surgery in patients with stage IV breast cancer with bone metastasis only (protocol bomet MF14-01); a multi-center, registry study | Soran, Atilla; Doğan, Lütfi; Özbaş, Serdar; Işık, Arda; Trablus, D.; Demirci, U.; Sezgin, Efe |
9 | Jun-2018 | Factors related to recurrence of idiopathic granulomatous mastitis: what do we learn from a multicentre study? | Uysal, Erdal; Soran, Atilla; Sezgin, Efe ; Granulomatous Mastitis Study Group |
10 | 2016 | The impact of Onco type DX® recurrence score of paraffin-embedded core biopsy tissues in predicting response to neoadjuvant chemotherapy in women with breast cancer | Soran, Atilla; Bhargava, Rohit; Johnson, Ronald; Ahrendt, Gretchen; Bonaventura, Marguerite; Diego, Emilia; McAuliffe, Priscilla F.; Serrano, Merida; Menekşe, Ebru; Sezgin, Efe ; McGuire, Kandace P. |
11 | Oct-2022 | Intervention for hepatic and pulmonary metastases in breast cancer patients: Prospective, multi-institutional registry Study-IMET, Protocol MF 14-02 | Soran, Atilla; Özbaş, Serdar; Özçınar, Beyza; Işık, Arda; Doğan, Lütfi; Şenol, Kazım; Dağ, Ahmet; Karanlık, Hasan; Aytaç, Özgür; Karadeniz Çakmak, Güldeniz; Dalcı, Kubilay; Doğan, Mutlu; Sezer, Atakan Y.; Gökgöz, Şehsuvar; Özyar, Enis; Sezgin, Efe |
12 | Apr-2022 | Intervention to hepatic and pulmonary METastases in breast cancer patients: Prospective, multi-institutional registry study-IMET; Protocol MF 14-02 | Soran, Atilla; Özbaş, Serdar; Özçınar, Beyza; Işık, Arda; Doğan, Lütfi; Şenol, Kazım; Dağ, Ahmet; Karanlık, Hasan; Aytaç, Özgür; Karadeniz Çakmak, Güldeniz; Dalcı, Kubilay; Doğan, Mutlu; Sezer, Atakan Y.; Gökgöz, Şehsuvar; Özyar, Enis; Sezgin, Efe |
13 | 2021 | A novel first-line treatment alternative for noncomplicated idiopathic granulomatous mastitis: Combined intralesional steroid injection with topical steroid administration | Toktaş, Osman; Konca, Can; Trabulus, Didem Can; Soyder, Aykut; Köksal, Hande; Karanlık, Hasan; Kamalı Polat, Ayfer; Özbaş, Serdar Mustafa; Yormaz, Serdar; Sezgin, Efe ; Soran, Atilla |
14 | 2021 | Primary surgery with systemic therapy in patients with de novo stage IV breast cancer: 10-year follow-up; protocol MF07-01 randomized clinical trial | Soran, Atilla; Özmen, Vahit; Özbaş, Serdar; Karanlık, Hasan; Müslümanoğlu, Mahmut; İğci, Abdullah; Cantürk, Nuh Zafer; Utkan, Zafer; Evrensel, Türkkan; Sezgin, Efe |
15 | 2018 | Randomized trial comparing resection of primary tumor with no surgery in stage IV breast cancer at presentation: Protocol MF07-01 | Soran, Atilla; Özmen, Vahit; Özbaş, Serdar; Karanlık, Hasan; Müslümanoğlu, Mahmut; İgci, Abdullah; Johnson, Ronald; Sezgin, Efe |
16 | 2021 | Reply: The effect of primary surgery in patients with stage IV breast cancer with bone metastasis only (Protocol BOMET MF 14-01): A multi-center, registry study | Soran, Atilla; Sezgin, Efe ; Özbaş, Serdar; Doğan, Lütfi |
17 | Jul-2021 | The role of loco-regional treatment in long-term quality of life in de novo stage IV breast cancer patients: protocol MF07-01Q | Soran, Atilla; Soyder, Aykut; Özbaş, Serdar; Özmen, Vahit; Karanlık, Hasan; İğci, Abdullah; Sezgin, Efe |
18 | May-2022 | Survival impact of intervention to distant metastatic lesions in patients with breast cancer | Abidi, Hira; Ayoade, Oluwaseun; McAuliffe, Priscilla; Johnson, Ronald; Lee, Joanna; Keenan, Donald; Steiman, Jennifer; Sezgin, Efe ; Soran, Atilla |